$75.2 Million
MeiraGTx Holdings plc
Confidentially Marketed Follow-On Offering
Active Bookrunner
$55.0 Million
Chiasma, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$126.5 Million
Cara Therapeutics Inc.
Confidentially Marketed Follow-On Offering
Passive Bookrunner
$57.7 Million
Alphatec Holdings, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$65.0 Million
Syros Pharmaceuticals, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$31.2 Million
Kiadis Pharma B.V.
Confidentially Marketed Follow-On Offering
Active Bookrunner
$40.0 Million
XBiotech, Inc.
Confidentially Marketed Follow-On Offering
Left Bookrunner
$63.3 Million
Fluidigm Corporation
Follow-On Offering
Left Bookrunner
$57.9 Million
SeaSpine Holdings Corporation
Confidentially Marketed Follow-On Offering
Active Bookrunner
$143.8 Million
Fate Therapeutics, Inc.
Confidentially Marketed Follow-On Offering
Active Bookrunner
Subscribe to Financing

© 2025 Piper Sandler Companies. Since 1895. All rights reserved.